Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers.

Abstract

Since second generation pneumococcal conjugate vaccines (PCVs) targeting 10 and 13 serotypes became available in 2010, the number of national policy makers considering these vaccines has steadily increased. An important consideration for a national immunization program is the timing and number of doses-the schedule-that will best prevent disease in the… (More)
DOI: 10.1097/INF.0000000000000076

Topics

5 Figures and Tables

Cite this paper

@article{Whitney2014DosingSF, title={Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers.}, author={Cynthia G. Whitney and David Goldblatt and Katherine L. O'Brien}, journal={The Pediatric infectious disease journal}, year={2014}, volume={33 Suppl 2}, pages={S172-81} }